Stephen Willey
Stock Analyst at Stifel
(3.68)
# 829
Out of 5,008 analysts
120
Total ratings
42.05%
Success rate
10.87%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stephen Willey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INCY Incyte | Maintains: Buy | $110 → $115 | $87.17 | +31.93% | 7 | Sep 22, 2025 | |
| XFOR X4 Pharmaceuticals | Maintains: Buy | $30 → $9 | $3.44 | +161.63% | 3 | Aug 29, 2025 | |
| INSM Insmed | Maintains: Buy | $121 → $145 | $162.32 | -10.67% | 7 | Aug 14, 2025 | |
| NKTX Nkarta | Maintains: Buy | $14 → $12 | $2.06 | +482.52% | 4 | Aug 14, 2025 | |
| ABCL AbCellera Biologics | Maintains: Buy | $8 → $7 | $5.77 | +21.32% | 7 | Aug 8, 2025 | |
| EXEL Exelixis | Maintains: Hold | $38 → $41 | $39.63 | +3.46% | 19 | Jul 29, 2025 | |
| CELC Celcuity | Reinstates: Buy | $30 | $49.22 | -39.04% | 1 | Jul 1, 2025 | |
| CBIO Crescent Biopharma | Initiates: Buy | $28 | $11.29 | +148.01% | 1 | Jun 25, 2025 | |
| MGNX MacroGenics | Maintains: Hold | $6 → $5 | $1.72 | +190.70% | 4 | May 14, 2025 | |
| BOLT Bolt Biotherapeutics | Maintains: Hold | $25 → $20 | $6.20 | +222.58% | 4 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $35 | $9.83 | +256.05% | 5 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $100 | $33.80 | +195.86% | 5 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $1.29 | +210.08% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $28 | $16.50 | +69.70% | 6 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $18.17 | +158.67% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $0.75 | +431.63% | 7 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $1.76 | +127.27% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $62 | $39.16 | +58.32% | 5 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $3.61 | +149.31% | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.65 | +627.27% | 1 | Nov 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $228 → $288 | $2.39 | +11,950.21% | 4 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $21 | $2.16 | +872.22% | 2 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $10 → $4 | $1.52 | +163.16% | 7 | Jul 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $123 | $459.58 | -73.24% | 3 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $48 → $47 | $68.94 | -31.82% | 2 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $102 → $109 | $54.70 | +99.27% | 3 | Aug 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Terminates: Hold | n/a | $17.20 | - | 2 | Jun 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $23 | $8.72 | +163.76% | 5 | Feb 7, 2018 |
Incyte
Sep 22, 2025
Maintains: Buy
Price Target: $110 → $115
Current: $87.17
Upside: +31.93%
X4 Pharmaceuticals
Aug 29, 2025
Maintains: Buy
Price Target: $30 → $9
Current: $3.44
Upside: +161.63%
Insmed
Aug 14, 2025
Maintains: Buy
Price Target: $121 → $145
Current: $162.32
Upside: -10.67%
Nkarta
Aug 14, 2025
Maintains: Buy
Price Target: $14 → $12
Current: $2.06
Upside: +482.52%
AbCellera Biologics
Aug 8, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $5.77
Upside: +21.32%
Exelixis
Jul 29, 2025
Maintains: Hold
Price Target: $38 → $41
Current: $39.63
Upside: +3.46%
Celcuity
Jul 1, 2025
Reinstates: Buy
Price Target: $30
Current: $49.22
Upside: -39.04%
Crescent Biopharma
Jun 25, 2025
Initiates: Buy
Price Target: $28
Current: $11.29
Upside: +148.01%
MacroGenics
May 14, 2025
Maintains: Hold
Price Target: $6 → $5
Current: $1.72
Upside: +190.70%
Bolt Biotherapeutics
May 13, 2025
Maintains: Hold
Price Target: $25 → $20
Current: $6.20
Upside: +222.58%
Apr 9, 2025
Maintains: Buy
Price Target: $36 → $35
Current: $9.83
Upside: +256.05%
Mar 21, 2025
Maintains: Buy
Price Target: $240 → $100
Current: $33.80
Upside: +195.86%
Feb 27, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.29
Upside: +210.08%
Oct 28, 2024
Maintains: Buy
Price Target: $21 → $28
Current: $16.50
Upside: +69.70%
Oct 8, 2024
Initiates: Buy
Price Target: $47
Current: $18.17
Upside: +158.67%
Aug 20, 2024
Maintains: Buy
Price Target: $8 → $4
Current: $0.75
Upside: +431.63%
Dec 19, 2023
Maintains: Buy
Price Target: $3 → $4
Current: $1.76
Upside: +127.27%
Dec 18, 2023
Maintains: Buy
Price Target: $53 → $62
Current: $39.16
Upside: +58.32%
Jan 27, 2023
Initiates: Buy
Price Target: $9
Current: $3.61
Upside: +149.31%
Nov 28, 2022
Initiates: Buy
Price Target: $12
Current: $1.65
Upside: +627.27%
Jun 26, 2020
Downgrades: Hold
Price Target: $228 → $288
Current: $2.39
Upside: +11,950.21%
Mar 17, 2020
Maintains: Buy
Price Target: $22 → $21
Current: $2.16
Upside: +872.22%
Jul 29, 2019
Downgrades: Hold
Price Target: $10 → $4
Current: $1.52
Upside: +163.16%
Aug 13, 2018
Maintains: Buy
Price Target: $125 → $123
Current: $459.58
Upside: -73.24%
Aug 8, 2018
Maintains: Hold
Price Target: $48 → $47
Current: $68.94
Upside: -31.82%
Aug 3, 2018
Maintains: Buy
Price Target: $102 → $109
Current: $54.70
Upside: +99.27%
Jun 25, 2018
Terminates: Hold
Price Target: n/a
Current: $17.20
Upside: -
Feb 7, 2018
Maintains: Buy
Price Target: $20 → $23
Current: $8.72
Upside: +163.76%